Singapore has its sights set on becoming a hub for health technology, and the city-state has developed a package of incentives to lure large employers and upstarts alike. The program includes tax credits for R&D spending, plus access to Singapore's cutting-edge telecom infrastructure and scientific talent graduating from the country's highly ranked engineering programs. The inducements seem to be working: In recent years pharmaceutical giants GlaxoSmithKline, Novartis, Abbott, and Roche have opened major operations in Singapore.
CEO Mark Zuckerberg would like to reach the country's 513 million Internet users. Too bad local entrepreneurs have beaten him to the punch.